JCR Pharmaceuticals Reports Half-Year Net Loss Versus Prior-Year Profit
JCR Pharmaceuticals reported a half-year net loss for the period ended September 30, 2026, compared with net profit in the prior-year period. Revenue declined year over year, while operating and pretax profit turned to losses.
JCR Pharmaceuticals Co. Ltd. (4552.TO) Japan Half-Year Ended September 30 GROUP 2026 2025 Revenue Y19.97 bln Y21.36 bln Operating Profit (Y3.50 bln) Y2.43 bln Pretax Profit (Y3.80 bln) Y2.41 bln Net Profit (Y3.8…